SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-20-145277
Filing Date
2020-05-19
Accepted
2020-05-18 18:49:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d901687ds3a.htm S-3/A 479461
2 EX-23.1 d901687dex231.htm EX-23.1 1686
3 GRAPHIC g901687g07e55.jpg GRAPHIC 39955
  Complete submission text file 0001193125-20-145277.txt   533088
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-238128 | Film No.: 20891154
SIC: 2834 Pharmaceutical Preparations